From Vascular Smooth Muscle Cells to Folliculogenesis: What About Vasorin?

Front Med (Lausanne)

EA 2496 Orofacial Pathologies, Imaging and Biotherapies, Dental School Faculty, University Paris Descartes and Life Imaging Platform (PIV), Montrouge, France.

Published: December 2018

First described in 1988, vasorin (VASN) is a transmembrane glycoprotein expressed during early mouse development, and with a less extent, in various organs and tissues (e.g., kidney, aorta, and brain) postnatally. KO mice die after 3 weeks of life from unknown cause(s). No human disease has been associated with variants of this gene so far, but VASN seems to be a potential biomarker for nephropathies and tumorigenesis. Its interactions with the TGF-β and Notch1 pathways offer the most serious assumptions regarding VASN functions. In this review, we will describe current knowledge about this glycoprotein and discuss its implication in various organ pathophysiology.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288187PMC
http://dx.doi.org/10.3389/fmed.2018.00335DOI Listing

Publication Analysis

Top Keywords

vascular smooth
4
smooth muscle
4
muscle cells
4
cells folliculogenesis
4
folliculogenesis vasorin?
4
vasorin? described
4
described 1988
4
1988 vasorin
4
vasorin vasn
4
vasn transmembrane
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!